Patent: 10,272,050
✉ Email this page to a colleague
Summary for Patent: 10,272,050
| Title: | Nanoparticles and methods of use |
| Abstract: | This disclosure relates to nanoparticles, compositions, methods of making, and methods of use thereof. |
| Inventor(s): | Farokhzad; Omid C. (Waban, MA), Choi; Won Il (Cambridge, MA), Andrian; Ulrich von (Chestnut Hill, MA), Kamaly; Nazila (Boston, MA) |
| Assignee: | The Brigham and Women\'s Hospital, Inc. (Boston, MA) President and Fellows of Harvard College (Cambridge, MA) |
| Application Number: | 15/519,052 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,272,050
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
|---|---|---|---|---|---|---|---|
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | October 28, 1982 | ⤷ Subscribe | 2034-10-14 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | December 29, 2015 | ⤷ Subscribe | 2034-10-14 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | August 06, 1998 | ⤷ Subscribe | 2034-10-14 |
| Eli Lilly And Company | HUMULIN R U-500 | insulin human | Injection | 018780 | March 31, 1994 | ⤷ Subscribe | 2034-10-14 |
| Eli Lilly And Company | HUMULIN R U-100 | insulin human | Injection | 018780 | May 25, 2018 | ⤷ Subscribe | 2034-10-14 |
| Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | June 25, 1991 | ⤷ Subscribe | 2034-10-14 |
| Novo Nordisk Inc. | NOVOLIN R | insulin human | Injection | 019938 | June 01, 2018 | ⤷ Subscribe | 2034-10-14 |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
